UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect

PloS one, 2014-10, Vol.9 (10), p.e109799-e109799

2014

Volltextzugriff (PDF)

SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution

PLoS computational biology, 2014-08, Vol.10 (8), p.e1003665-e1003665

2014

Volltextzugriff (PDF)

ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insights

Frontiers in immunology, 2024-09, Vol.15, p.1432799

2024

Volltextzugriff (PDF)

Targeting CXCR4 in AML and ALL

Frontiers in oncology, 2020-09, Vol.10, p.1672-1672

2020

Volltextzugriff (PDF)

Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia

Journal of clinical oncology, 2010-02, Vol.28 (4), p.556-561

2010

Volltextzugriff (PDF)

Mouse models of graft-versus-host disease: advances and limitations

Disease models & mechanisms, 2011-05, Vol.4 (3), p.318-333

2011

Volltextzugriff (PDF)

Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4767-4773

2009

Volltextzugriff (PDF)

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

Journal of hematology and oncology, 2017-02, Vol.10 (1), p.55-14, Article 55

2017

Volltextzugriff (PDF)

Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantation

PloS one, 2018-11, Vol.13 (11), p.e0207609

2018

Volltextzugriff (PDF)

Traversing the bench to bedside journey for iNKT cell therapies

Frontiers in immunology, 2024-08, Vol.15, p.1436968

2024

Volltextzugriff (PDF)

Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencing

PLoS genetics, 2014-07, Vol.10 (7), p.e1004462-e1004462

2014

Volltextzugriff (PDF)

Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model

Molecules (Basel, Switzerland), 2024-04, Vol.29 (8), p.1801

2024

Volltextzugriff (PDF)

Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager

PloS one, 2024-05, Vol.19 (5), p.e0300174

2024

Volltextzugriff (PDF)

A systematic framework for predictive biomarkers in immune effector cell-associated neurotoxicity syndrome

Frontiers in neurology, 2023-02, Vol.14, p.1110647

2023

Volltextzugriff (PDF)

Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors?

Frontiers in oncology, 2020-12, Vol.10, p.608916

2020

Volltextzugriff (PDF)

GPR18 Controls Reconstitution of Mouse Small Intestine Intraepithelial Lymphocytes following Bone Marrow Transplantation

PloS one, 2015-07, Vol.10 (7), p.e0133854-e0133854

2015

Volltextzugriff (PDF)

Genomic tools in acute myeloid leukemia: From the bench to the bedside

Cancer, 2014-04, Vol.120 (8), p.1134-1144

2014

Volltextzugriff (PDF)

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

Scientific reports, 2022-01, Vol.12 (1), p.30-30, Article 30

2022

Volltextzugriff (PDF)

A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma

Scientific reports, 2021-09, Vol.11 (1), p.19343-19343, Article 19343

2021

Volltextzugriff (PDF)

Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2004-03, Vol.22 (6), p.1095-1102

2004

Volltextzugriff (PDF)

Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models

Frontiers in immunology, 2023-09, Vol.14, p.1264496-1264496

2023

Volltextzugriff (PDF)

F11R is a novel monocyte prognostic biomarker for malignant glioma

PloS one, 2013-10, Vol.8 (10), p.e77571-e77571

2013

Volltextzugriff (PDF)

Integration of Clinical Trial Development in Hematology-Oncology Fellowship Training

Academic medicine, 2024-05

2024

Volltextzugriff (PDF)

Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells

Current opinion in hematology, 2010-07, Vol.17 (4), p.319-326

2010

Volltextzugriff (PDF)

Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis

PloS one, 2012-05, Vol.7 (5), p.e37203

2012

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect

SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution

ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insights

Targeting CXCR4 in AML and ALL

Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia

Mouse models of graft-versus-host disease: advances and limitations

Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantation

Traversing the bench to bedside journey for iNKT cell therapies

Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencing

Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model

Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager

A systematic framework for predictive biomarkers in immune effector cell-associated neurotoxicity syndrome

Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors?

GPR18 Controls Reconstitution of Mouse Small Intestine Intraepithelial Lymphocytes following Bone Marrow Transplantation

Genomic tools in acute myeloid leukemia: From the bench to the bedside

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma

Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models

F11R is a novel monocyte prognostic biomarker for malignant glioma

Integration of Clinical Trial Development in Hematology-Oncology Fellowship Training

Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells

Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis

Aktive Filter

Suchergebnisse filtern